MarketInOut Stock Screener Log In | Sign Up
 

Dyne Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Dyne Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,944.99 mln
Float157 mln
Earnings Date10/29/2026

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

35.73
Transformational upside

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.33
Low leverage

ROE

-68.30
Deeply negative

ROA

-53.47
Deeply negative

Business Description

Dyne Therapeutics is a US-based medical company working to develop treatments for serious muscle diseases, including myotonic dystrophy, Duchenne muscular dystrophy, and Pompe disease, among others. Founded in 2017 and based in Waltham, Massachusetts, the company uses its proprietary FORCE platform to get these treatments directly to muscle tissue where they are needed most.

Key Fundamentals

EPS-3.30
ROE-68.30
ROIC-714
ROA-53.47
Interest Cover-36.05
EBITDA, mln-502
EV / EBITDA-4.66
EV / EBIT-4.64

Quote Details

Last 15.62
Change -0.15 (-0.95%)
Open 15.92
Volume 2,134,278
Turnover 33,337,422
Average Volume 3,083,508

Financial Ratios

Leverage Ratio1.42
Current Ratio12.02
Price / Book3.80
Price / Tangible Book3.80
Debt / Equity0.33

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price35.73
Short Ratio7.25
Short % of Float17.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.61% 97 / 100   
1 Month -5.39% 22 / 100   
2 Months -33.39% 4 / 100   
6 Months -14.46% 17 / 100   
1 Year -4.46% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog